Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis (NCT01892722)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (73 Sites)

• UAB Childrens Hospital Harbor Center Neurology Dept — Birmingham, Alabama
• Childrens Hospital Los Angeles — Los Angeles, California
• UCSF — San Francisco, California
• University of Miami — Miami, Florida
• AMO Corporation — Tallahassee, Florida
• Massachusetts General Hospital — Boston, Massachusetts
• Wayne State University — Detroit, Michigan
• Robert Wood Johnson Medical School — New Brunswick, New Jersey
• Childrens Hospital of Philadelphia — Philadelphia, Pennsylvania
• University of Utah Clinical Trials Office — Salt Lake City, Utah
• Novartis Investigative Site — Parkville, Victoria
• Novartis Investigative Site — Vienna,
• Novartis Investigative Site — Belo Horizonte, Minas Gerais
• Novartis Investigative Site — Rio de Janeiro, Rio de Janeiro
• Novartis Investigative Site — São Paulo, São Paulo
• Novartis Investigative Site — Goiânia,
• Novartis Investigative Site — Sofia,
• Novartis Investigative Site — Calgary, Alberta
• Novartis Investigative Site — Ottawa, Ontario
• Novartis Investigative Site — Osijek,
• Novartis Investigative Site — Tallinn,
• Novartis Investigative Site — Bordeaux,
• Novartis Investigative Site — Le Kremlin-Bicêtre,
• Novartis Investigative Site — Marseille,
• Novartis Investigative Site — Montpellier,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.